News | May 15, 2007

Body Parts Scam Tops 450 Cases

May 16, 2007 — More than 450 people nationwide now claim they received illegally obtained and possibly diseased body parts from a New Jersey-based scheme, according to court documents.
The FDA has said it's concerned that the bone and tissue could be infected with the AIDS virus, syphilis and hepatitis, but the risk of infection is small.

The FDA, which did not return requests for comment, has not said whether any patients have ailments linked to the tissue, nor has it revealed how many people received it.

However, a document filed in a South Dakota lawsuit states that 13 plaintiffs nationwide claim they have contracted a disease.

The South Dakota case was brought by Charles Geigle of Oliver County, N.D., who claims he received transplanted bone tissue that might be infected.

He had back surgery April 30, 2004, at Sioux Valley Hospital in Sioux Falls, according to his complaint filed in U.S. District Court.

Defendants in the lawsuit, which seeks class-action status, have asked for a delay so they can argue that it should be transferred to the Judicial Panel on Multidistrict Litigation, which coordinates identical federal civil lawsuits into one jurisdiction.

Of the 451 cases filed so far, 189 are in federal courts and 134 of them have been transferred to the panel, court documents state. Two other South Dakota cases are among those that have been transferred.

"The need for coordination of this national litigation is compelling. The multiple proposed classes, as well as the individual actions, are overlapping. The complaints contain virtually identical allegations in many cases," according to one document in Geigle's case.

He received a letter in December 2005 from a doctor telling him the bone tissue he received might have been illegally acquired and that he could be at risk of getting a disease.

The supplier was Biomedical Tissue Services, a now-defunct Fort Lee, N.J., company owned by former dentist Michael Mastromarino, who made millions of dollars from the scheme, prosecutors have said.

He and three other men are accused of secretly removing skin, bone and other parts from up to 1,000 bodies from funeral homes without the families' permission.

"When a funeral was scheduled to be 'open casket,' harvested bone taken from the deceased was replaced with PVC pipe and other objects so the bodies would still appear normal during the funeral proceedings," court documents state.

The men also changed the names of the donors, medical records, death certificates and other information "in order to conceal the lifestyle and medical history of the donors," the documents said.

BTS supplied bone, skin and tendons to various processors that in turn provided the body parts to distributors for common procedures such as dental implants and hip replacements. Some of the tissue came from bodies that were not eligible to be donors because of age, disease or illness, according to Geigle's lawsuit.

Because of that, Geigle said he and perhaps thousands of others now live in fear they or their spouses have been exposed to a deadly disease. He seeks more than $5 million in damages for patients who received BTS tissue from 2002 to 2005.

Geigle received bone that was processed and packaged by Regeneration Technologies Inc., a Delaware corporation, and distributed by SpinalGraft Technologies of Tennessee, a division of Minneapolis-based distributor Medtronic Inc. -- all of which are listed as defendants.

The FDA ordered BTS to stop operating because of the serious nature of the violations and ordered a recall of all products, which the other defendants complied with, the lawsuit states.

The FDA and Centers for Disease Control also urged people who received BTS tissue be tested for infectious disease.

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...